Taiwan Global Biofund
Established in July 2005, Taiwan Global Fund manages over US$68 million worth of funds, investing in more than 20 startup biotech companies in territories such as Taiwan, Asia and the US. The expert teams at Taiwan Global Fund, its strategic partners and Steering Committee are not only competent in making investment decisions, but also help to build the value of portfolio companies and to accelerate their growth and development.

Burrill & Company
Burrill & Company is a life sciences merchant bank focused exclusively on companies involved in biotechnology, pharmaceuticals, diagnostics, devices, human healthcare and related medical technologies, nutraceuticals and wellness, agricultural biotechnology, and industrial biotechnology (biomaterials/bioprocesses) with over $950 million under management. Burrill is also the sponsor and facilitator of several leading annual industry conferences and publishes the seminal annual report on the state of the biotechnology industry. This combination of resources and capabilities has helped Burrill develop a unique and highly effective platform for finding and making outstanding life science investments.
www.burrillandco.com

Boston Life Science Venture Corp.
As an associated company of the Industrial Bank of Taiwan (IBT) Group, Boston Life Science Venture Corp. was established in 2003 with an investment focus on biotech and life science industries. Total fund size reached NT$ 2 billion and is used to invest in 20 companies, 80% of which are companies located in the U.S. and Europe and 20% are companies in Taiwan. The portfolio companies engage in areas such as new drug development, drug test and manufacturing, healthcare products and medical equipment. Lately, the coverage of the fund expanded into emerging industries such as agriculture biotech, biotech energy, biotech material and integrated digital treatment and service.
www.ibtm.com.tw

Eminent Venture Capital Fund
Eminent Venture Capital Fund is managed by TaiAn Technologies Corp. TaiAn Technologies was founded in 2002, their shareholders include domestic conglomerates such as China Steel Corporation, Far Eastern Group, TECO Group, Taiwan Fertilizer, China Steel Chemicals, and Mega International Commercial Bank, National Development Fund of Executive Yuan, etc. TaiAn expanded into venture capital management in life sciences, besides Eminent Venture Capital Fund, they are also managing a government tender side fund since 2005. TaiAn's investment focus includes pharmaceuticals, medical devices, diagnostic products and medical instruments, they are seeking to explore join venture opportunities with foreign companies planning to integrate Taiwan’s competitive capabilities in manufacturing, clinical development and regional sales/distribution.

back to top